Showing results (111-120 of 715) with videos related to

Sort By:
Pageof 72
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2013
Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infectionsSergio Serrano-Villar, Carmen Quereda, Ana Moreno, et al.
AIDS (London, England)|February 9, 2012
Association of tenofovir exposure with kidney disease risk in HIV infectionRebecca Scherzer, Michelle Estrella, Yongmei Li, et al.
Plos Computational Biology|December 3, 2010
Treatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral loadNaveen K Vaidya, Libin Rong, Vincent C Marconi, et al.
Journal of Virology|January 26, 2007
Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitorsNeelanjana Ray, Jessamina E Harrison, Leslie A Blackburn, et al.
Plos One|December 5, 2012
Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infectionAdam S Lauring, Tzong-Hae Lee, Jeffrey N Martin, et al.
Trends in Immunology|May 17, 2020
'Rinse and Replace': Boosting T Cell Turnover To Reduce HIV-1 ReservoirsZvi Grossman, Nevil J Singh, Francesco R Simonetti, et al.
Computational Statistics & Data Analysis|September 28, 2011
Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatmentChristina M R Kitchen, Jing Kroll, Daniel R Kuritzkes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2018
Differential Expression of CD8<sup>+</sup> T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 InfectionBrenna E Kiniry, Peter W Hunt, Frederick M Hecht, et al.
Pageof 72